Riskpilot← Back to searchSign inGet full accessLifeline Research Oy
OYDissolvedY-tunnus 2793033-9Pursimiehenkatu 26-CResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employees
Revenue 2024
EUR 0
EBITDA margin
—
+15% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
EUR -31K
-177% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -8K | +15% |
| Net profit | EUR -31K | -177% |
| Total assets | EUR 896K | -8% |
| Equity | EUR 894K | -8% |
| Employees | 0 | — |
Legal name
Lifeline Research Oy
Y-tunnus number
2793033-9
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4. marraskuuta 2016
Share capital
EUR 2 520
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on teknologioiden testaaminen, kehittäminen ja patentoiminen sekä konsultointi näihin liittyen. Lisäksi yhtiön toimialana on sijoitustoiminta. Yhtiö voi toimintaa harjoittaessaan omistaa ja hallita kiinteistöjä sekä antaa niitä vuokralle. Toimialansa rajoissa yhtiö voi myös perustaa koti- ja ulkomaisia yhtiöitä ja yhtymiä sekä hankkia, omistaa ja hallita osakkeita, osuuksia ja arvopapereita.
Address
Pursimiehenkatu 26-C
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | −6 | 9 217 | −11 | −9 | −8 |
| Depreciation & amort. | −11 | −11 | −2 | −2 | −23 |
| EBIT | −17 | 9 206 | −13 | −11 | −31 |
| Net financials | −88 | −37 | 0 | 0 | 0 |
| Profit before tax | −105 | 9 169 | −13 | −11 | −31 |
| Tax | −0 | 1 731 | −0 | −0 | −0 |
| Net profit | −105 | 7 439 | −13 | −11 | −31 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 011 | 1 000 | 987 | 975 | 896 |
| Equity | −512 | 999 | 986 | 975 | 894 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 1 522 | 1 | 1 | 1 | 2 |
| Total debt | 1 522 | 1 | 1 | 1 | 2 |
EBITDA margin
-759600.0%
This company
15.8%
Market median
-4807695% vs market
20202024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
-3.4%
This company
18.4%
Market median
-118% vs market
20202024
Net profit margin
-3065100.0%
This company
8.1%
Market median
-37840841% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SM Deputy Member | Deputy Member | 2016 |
KP Chief Executive Officer | Chief Executive Officer | 2016 |
| Former (2) | ||
MJ | Audit | 2016 – 2022 |
| Audit | 2022 – 2023 | |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lifeline Research Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Markku Juhani Katajisto | Audit | 0 companies |
| Samuli Matias Leppänen | Deputy Member | 0 companies |
| Valtteri Matti Eemeli Helenius | Audit | 0 companies |
| Kai Peter Gunnar Bäckman | Chief Executive Officer | 0 companies |